Related Experiment Video
Updated: Jul 3, 2026

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Published on: December 15, 2011
The prevalence of celiac disease in blood donors in Iceland
Gudmundur F Johannsson1, Gudjon Kristjansson, Nick Cariglia
1Department of Medicine, FSA University Hospital, 600, Akureyri, Iceland.
Insights
The prevalence of celiac disease in Iceland was found to be 0.74% among blood donors. This finding indicates that celiac disease is as common in Iceland as in other countries.
Area of Science:
- Epidemiology
- Gastroenterology
- Immunology
Background:
- Celiac disease is more prevalent than previously recognized, according to serological studies.
- Understanding the prevalence of celiac disease in diverse populations is crucial.
Purpose of the Study:
- To determine the prevalence of celiac disease in apparently healthy Icelandic blood donors.
- To contribute to the epidemiological understanding of celiac disease.
Main Methods:
- Screening of 813 blood donor plasma samples for human tissue transglutaminase IgA antibodies.
- Positive serological results were confirmed through clinical examination, duodenoscopy, and mucosal biopsies.
Main Results:
- Six subjects tested positive for tissue transglutaminase antibodies.
- Biopsy-confirmed celiac disease prevalence was determined to be 1:136 (0.74%) among blood donors.
- The 95% confidence interval for prevalence was 0.15-1.33%.
Conclusions:
- The prevalence of celiac disease in Iceland is comparable to that reported globally.
- This study highlights the importance of screening in blood donor populations.
Background:
Prospective epidemiological studies based on serological methods have shown that celiac disease is more common than previously thought. The aim of this study was to evaluate the prevalence of celiac disease among apparently healthy blood donors in Iceland.
Methods:
Plasma samples were obtained from 813 apparently healthy blood donors at the FSA Hospital Blood Bank in Akureyri, Iceland, between December 2004 and January 2007 and screened for human tissue transglutaminase IgA antibodies. Positive samples were retested and, if the test was again positive, the subject was referred to a gastroenterologist for clinical examination and a duodenoscopy with mucosal biopsies.
Results:
Six subjects tested positive for tissue transglutaminase. The prevalence of biopsy-confirmed celiac disease, according to modified Marsh classification, among apparently healthy blood donors in Iceland was found to be 1:136 (0.74%, 95% confidence interval 1/667-1/75, 0.15-1.33%).
Conclusion:
Prevalence of celiac disease in Iceland is similar to what has been reported in many other countries.
Related Concept Videos
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Blood Types
ABO blood group
ABO antigens are glycoproteins encoded by genes present on...
Transcytosis of IgG
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Rh Blood Group
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

